IP Library Granted Patent US 10,072,250
Granted Patent B2
US 10,072,250 · App. 14/900,837 · Granted Sep 11, 2018

Method for manufacturing non-enveloped virus

Inventors: Shuhei Sakamoto (Kusatsu, JP); Yasuhiro Kawano (Moriyama, JP); Katsuyuki Dodo (Kusatsu, JP); Tatsuji Enoki (Kyotanabe, JP); Hirofumi Yoshioka (Rittou, JP); Hikaru Takakura (Kyoto, JP); Junichi Mineno (Uji, JP)
Assignee: TAKARA BIO INC.
C12N7/00C12N2750/14151
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,072,250
App. No.
14/900,837
Granted
Sep 11, 2018
Kind
B2
Abstract

The present invention provides a method for efficiently manufacturing a non-enveloped virus with high purity without laborious operation by cultivating cells having the ability to produce a non-enveloped virus and bringing the cells and an acidic solution into contact with each other. A non-enveloped virus vector manufactured by the method of the present invention and a composition having the non-enveloped viral vector as an active ingredient are very useful as gene transfer methods in the fields of basic research and clinical application gene therapy.

Claims (12)

1. A method of producing a non-enveloped virus, the method comprising:

(a) culturing an isolated cell, wherein a non-enveloped virus is replicating within said cell,

(b) removing the culture solution or media from the cell,

(c) bringing the cell into contact with an acidic solution, and

(d) isolating the non-enveloped virus from the cell and acidic solution mixture of step (c),

wherein the non-enveloped virus is an adeno-associated virus, and wherein the acidic solution is at pH 3.0-6.9.

2. The method according to claim 1 , wherein the acidic solution contains a sodium ion and/or a potassium ion.

3. The method according to claim 1 , wherein the virus is further purified after isolation in step (d).

4. The method according to claim 3 , wherein the purification of the non-enveloped virus is performed by an operation selected from ultracentrifugation, chromatography, and ultrafiltration.

5. The method according to claim 1 , wherein the acidic solution contains a cation and citric acid.

6. The method according to claim 1 , wherein the isolation of step (d) is performed via centrifugation or filtration.

7. The method according to claim 1 , which does not comprise a physical cell disruption method.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 29, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039206/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2015
From: SAKAMOTO, SHUHEI; KAWANO, YASUHIRO; DODO, KATSUYUKI; ENOKI, TATSUJI; YOSHIOKA, HIROFUMI; TAKAKURA, HIKARU; MINENO, JUNICHI
To: TAKARA BIO INC.
Reel/Frame 037352/0485 →
Priority Claims (1)
JP 2013-145325 · Jul 11, 2013 · national
Continuity (1)
Related Publication 20160152955A1 · Jun 2, 2016